Home›Research›Compare›Carnosine vs CJC-1295 DAC
Peptide ComparisonCarnosine vs CJC-1295 DAC
Carnosine
Beta-alanyl-L-histidine
Half-life: ~30-40 minutes
5 providers listed
CJC-1295 DAC
CJC-1295 with DAC
Half-life: 6–8 days
1 providers listed
Carnosine and CJC-1295 DAC target different goals — Carnosine for intramuscular pH buffering, CJC-1295 DAC for GH and IGF-1 elevation studied in a single-dose human PK trial. They're compared here for reference, not as direct substitutes.
Carnosine
Half-life
~30-40 minutes
CJC-1295 DAC
Half-life
6–8 days
Carnosine and CJC-1295 DAC target different goals — Carnosine for Muscle & Myostatin, CJC-1295 DAC for GH / IGF Axis. They're compared here for reference; there isn't a single “better” choice between them.
Carnosine
CJC-1295 DAC
Carnosine
beta-Alanine supplementation augments muscle carnosine content and attenuates fatigue during repeated isokine…
Identification of acryloyl-histidine-related components from heat-denatured imidazole dipeptides and heated m…
L-carnosine attenuates endometrial fibrosis by targeting the ERK/PTGS2 axis.
Tissue-dependent enzymatic control of N-acetyl-β-alanine by PTER.
+4 more
About Carnosine
Dipeptide that buffers lactic acid in muscle during high-intensity exercise; chelates metal ions; prevents and reverses protein glycation; scavenges aldehyde oxidative byproducts
About CJC-1295 DAC
CJC-1295 DAC is a GHRH analog carrying a Drug Affinity Complex (DAC) modification that binds covalently to circulating albumin, greatly extending its plasma half-life relative to unmodified or short-acting GHRH analogs. Through this albumin binding it acts as a long-lasting agonist at pituitary GHRH receptors, associated in research with sustained growth hormone and downstream IGF-1 elevation. This contrasts with the non-DAC form (Mod GRF 1-29), whose action is measured in minutes rather than days.
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
Carnosine
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
CJC-1295 DAC
Class-based (investigational)
Research protocols routinely measure IGF-1 to track GH axis activity before and during use. Fasting glucose and insulin are monitored because GH elevation can reduce insulin sensitivity over time.
global — WADA
This compound falls under WADA Prohibited List category S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), prohibited at all times for competing athletes.
sourceCarnosine
Not enough vendor pricing yet.
CJC-1295 DAC
Where to source these peptides
Carnosine
5 listed
Browse directory →
Providers offeringCJC-1295 DAC
1 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
Related Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated August 26, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). Carnosine vs CJC-1295 DAC — Per-mg Price Comparison. Retrieved September 11, 2026, from https://peptidebase.io/peptides/compare/carnosine/cjc-1295-dac